Biomedical-Science.net


   

Search again
Google


Subscribe
Subscribe to this site.


About
Biomedical-Science.net, The cutting edge of biomedicine


Categories

       

home :: lung_cancer :: Mitogen-activated_protein_kinase_pathway.txt

Wed, 24 May 2006


Mitogen-activated protein kinase pathway was significantly activated in human bronchial epithelial cells by nicotine.

DNA Cell Biol 2006 May; 25(5): 312-22 (Read article online)
Tsai JR, Chong IW, Chen CC, Lin SR, Sheu CC, Hwang JJ

Nictoine is potentially associated with the onset of chronic obstructive pulmonary disease (COPD) and lung cancer. To gain insights into the molecular mechanism underlying such nicotine-induced conditions, microarray- bioinformatics analysis was carried out in the present study to explore the gene expression profiles in human bronchial epithelial cells (HBECs) treated with 5 muM nicotine for 4, 8, and 10 h. Of 1800 assessed genes overall, 260 (14.4%) were upregulated and 17 (0.9%) downregulated significantly. Gene ontology analysis demonstrated that most of the differentially expressed genes belonged to the category of molecular function, especially to the subcategories of enzyme activity. The integration of obtained information with bioinformatics tools in DAVID and KEGG databases indicated that the greatest number of overexpressed genes was involved in mitogen-activated protein kinase (MAPK) pathway. Membrane array analysis subsequently suggested that both extracellular signal-regulated kinase (ERK) 1/2 and c-Jun-NH(2)-terminal kinase (JNK) signalings but not p38 MAPK signaling were activated in response to nicotine. Pretreatment of HBECs with specific inhibitors against ERK 1/2 and JNK but not p38 could significantly inhibit nicotine-induced interleukin- 8 production. These results suggest that MAPK pathway may mediate the effect of nicotine through ERK 1/2 and JNK but not p38 in HBECs treated with nicotine.

/lung_cancer articles | Save This Page | writeback | permanent link



   
eXTReMe Tracker